PS
DNA icon

Principal Securities’s Ginkgo Bioworks DNA Stock Holding History

Principal Securities’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-103
Closed -$1.5K – 1889
2025
Q3 		$1.5K Hold
103
– – ﹤0.01% 3299
2025
Q2 		$1.16K Sell
103
-42
-29% -$325 ﹤0.01% 3301
2025
Q1 		$1.42K Hold
145
– – ﹤0.01% 3130
2024
Q4 		$1.42K Sell
145
-18
-11% -$154 ﹤0.01% 3124
2024
Q3 		$1.33K Buy
163
+95
+140% +$952 ﹤0.01% 3067
2024
Q2 		$911 Sell
68
-15
-18% -$448 ﹤0.01% 3089
2024
Q1 		$3.85K Buy
83
+2
+2% +$104 ﹤0.01% 2689
2023
Q4 		$5.49K Buy
+81
New +$4.96K ﹤0.01% 2501

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Securities's DNA Position: Q4 2025 in Review

Principal Securities sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 103 shares — an estimated $1.5K sold.

Principal Securities first reported a position in DNA in Q4 2023 and held it in 8 quarters. The position peaked at $5.49K in Q4 2023. 180 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Principal Securities reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 103 Ginkgo Bioworks shares in Q4 2025, an estimated $1.5K.
  • Principal Securities first reported a position in Ginkgo Bioworks in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Ginkgo Bioworks position peaked at $5.49K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.